CC
XLRN

Centiva Capital’s Acceleron Pharma XLRN Stock Holding History

Centiva Capital’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$172K – 1672
2021
Q3 		$172K Buy
+1,000
New +$131K 0.01% 957

Centiva Capital's XLRN Position: Q4 2021 in Review

Centiva Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 10,000 shares — an estimated $1.72M sold.

Centiva Capital first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $1.72M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Centiva Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Centiva Capital sold 10,000 Acceleron Pharma shares in Q4 2021, an estimated $1.72M.
  • Centiva Capital first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
  • Centiva Capital's Acceleron Pharma position peaked at $1.72M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Centiva Capital's 13F filing for Q4 2021, filed 14 Feb 2022.